Violeta Kvedarienė

ORCID: 0000-0002-6119-211X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Drug-Induced Adverse Reactions
  • Respiratory and Cough-Related Research
  • Food Allergy and Anaphylaxis Research
  • Contact Dermatitis and Allergies
  • Health and Medical Studies
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Delphi Technique in Research
  • Urticaria and Related Conditions
  • Dermatology and Skin Diseases
  • Air Quality and Health Impacts
  • Pharmacovigilance and Adverse Drug Reactions
  • Behavioral Health and Interventions
  • Olfactory and Sensory Function Studies
  • Nasal Surgery and Airway Studies
  • Global Healthcare and Medical Tourism
  • Immunodeficiency and Autoimmune Disorders
  • Noise Effects and Management
  • Pharmaceutical studies and practices
  • Mast cells and histamine
  • Air Quality Monitoring and Forecasting
  • Occupational exposure and asthma
  • Autoimmune Bullous Skin Diseases
  • Inhalation and Respiratory Drug Delivery

Vilnius University
2016-2025

State Research Institute Centre for Innovative Medicine
2023-2024

Vilnius University Hospital Santariskiu Klinikos
2002-2022

Institute of Biomedical Science
2022

Humboldt-Universität zu Berlin
2021

Charité - Universitätsmedizin Berlin
2021

Sanofi (France)
2021

Takeda (Italy)
2021

Novartis (Ireland)
2021

ENT and Allergy
2021

Anaphylaxis, which is rare, has been reported after COVID-19 vaccination, but its management not standardized.Members of the European Network for Drug Allergy and Academy Clinical Immunology interested in drug allergy participated an online questionnaire on pre-vaccination screening allergic reactions to vaccines, literature was analysed.No death due anaphylaxis vaccines confirmed scientific literature. Potential allergens, polyethylene glycol (PEG), polysorbate tromethamine are excipients....

10.1111/all.15241 article EN Allergy 2022-02-03

10.1016/j.jaci.2019.01.053 article EN publisher-specific-oa Journal of Allergy and Clinical Immunology 2019-04-03

The coronavirus disease 2019 (COVID-19) has evolved into a pandemic infectious transmitted by the severe acute respiratory syndrome (SARS-CoV-2). Allergists and other healthcare providers (HCPs) in field of allergies associated airway diseases are on front line, taking care patients potentially infected with SARS-CoV-2. Hence, strategies practices to minimize risks infection for both HCPs treated have be developed followed allergy clinics.The scientific information COVID-19 was analysed...

10.1111/all.14453 article EN Allergy 2020-06-12

Summary Background Mobile technology may help to better understand the adherence treatment. MASK ‐rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient‐centred ICT system. A mobile phone app (the Allergy Diary) central available in 22 countries. Objectives To assess treatment rhinitis patients using Diary App. Methods An observational cross‐sectional study was carried out on all users who filled from 1 January 2016 August 2017. Secondary assessed by modified...

10.1111/cea.13333 article EN Clinical & Experimental Allergy 2018-12-31
Jean Bousquet Marek Jutel Cezmi A. Akdiş Ludger Klimek Oliver Pfaar and 95 more Kari C. Nadeau Thomas Eiwegger Anna Bedbrook Ignacio J. Ansotegui Josep M Antó Claus Bachert Eric Bateman Kazi S. Bennoor Camelia Elena Berghea Karl‐Christian Bergmann Hubert Blain Mateo Bonini Sinthia Bosnic‐Anticevich Louis‐Philippe Boulet Luisa Brussino Roland Buhl Paulo Augusto Moreira Camargos Giorgio Walter Canonica Victòria Cardona Thomas B. Casale R. Sharon Chinthrajah Mübeccel Akdiş Tomás Chivato George Christoff Álvaro A. Cruz Heather J. Zar Stefano Del Giacco Hui Du Yehia El‐Gamal Wytske J. Fokkens João Fonseca Yadong Gao Mina Gaga Bilun Gemicioğlu Maia Gotua Tari Haahtela David Halpin Eckard Hamelmann Karin Hoffmann‐Sommergruber Marc Humbert N I Ilina Juan Carlos Ivancevich Guy Joos Musa Khaitov Bruce Kirenga Edward F. Knol Fanny W.S. Ko Seppo Koskinen Marek L. Kowalski Helga Kraxner D.А. Кudlay Piotr Kuna Maciej Kupczyk Violeta Kvedarienė Amir Hamzah Abdul Latiff Lan T. Le Michael Levin Désirée Larenas‐Linnemann Renaud Louis Mohammad Reza Masjedi Erik Melén Florin Mihaltan Branislava Milenković Yousser Mohammad Mário Morais‐Almeida Joaquim Mullol Leyla S. Namazova-Baranova Hugo Neffen Elisabete Nunes Paul M. O’Byrne Robyn E. O’Hehir Liam O’Mahony Ken Ohta Yoshitaka Okamoto Gabrielle L. Onorato Petr Panzner Nikolaos G. Papadopoulos Gianni Passalacqua Vincenzo Patella Ruby Pawankar N. Pham‐Thi Bernard Pigearias Todor A. Popov Francesca Puggioni Frederico S. Regateiro Giovanni Rolla Menachem Rottem Bolesław Samoliński J. Sastre Jürgen Schwarze Aziz Sheikh Nicola Scichilone Manuel Soto-Quirós Manuel E. Soto‐Martínez Milan Sova

To the Editor, A novel strain of human coronaviruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), named by International Committee on Taxonomy Viruses (ICTV),1 has recently emerged and caused an infectious disease. This disease is referred to as "coronavirus 2019" (COVID-19) World Health Organization (WHO).2 The US Centers for Disease Control Prevention (CDC) have proposed that "People with moderate asthma may be at higher risk getting very sick from COVID-19. COVID-19 can...

10.1111/all.14471 article EN cc-by-nc Allergy 2020-06-27
Jan Hagemann Gabrielle L. Onorato Marek Jutel Cezmi A. Akdiş Ioana Agache and 95 more Torsten Zuberbier Heather J. Zar Joaquim Mullol Anna Bedbrook Claus Bachert Kazi Saifuddin Bennoor Karl‐Christian Bergmann Fulvio Braido Paulo Augusto Moreira Camargos Luis Caraballo Victòria Cardona Thomas B. Casale Lorenzo Cecchi Tomás Chivato Derek K. Chu Cemal Cingi Jaime Correia de Sousa Stefano Del Giacco D Dokic Mark S. Dykewicz Motohiro Ebisawa Yehia El‐Gamal R. Emuzyte Jean‐Luc Fauquert Alessandro Fiocchi Wytske J. Fokkens João Fonseca Bilun Gemicioğlu René‐Maximiliano Gomez Maia Gotua Tari Haahtela Eckard Hamelmann Tomohisa Iinuma Juan Carlos Ivancevich Ewa Jassem Ömer Kalaycı Przemysław Kardas Musa Khaitov Piotr Kuna Violeta Kvedarienė Désirée Larenas‐Linnemann Brian J. Lipworth Michaël Makris Jorge Máspero Neven Miculinić Florin Mihălţan Yousser Mohammad Stephen Montefort Mário Morais‐Almeida Ralph Mösges Robert M. Naclerio Hugo Neffen Marek Niedoszytko Robyn E. O’Hehir Ken Ohta Yoshitaka Okamoto Kimi Okubo Petr Panzner Nikolaos G. Papadopoulos Giovanni Passalacqua Vincenzo Patella Ana Margarida Pereira Oliver Pfaar Davor Plavec Todor A. Popov Emmanuel P. Prokopakis Francesca Puggioni Filip Raciborski Jere Reijula Frederico S. Regateiro Sietze Reitsma Antonino Romano Nelson Augusto Rosário Filho Menachem Rottem Dermot Ryan Bolesław Samoliński J. Sastre Dirceu Solé Milan Sova Cristiana Stellato Charlotte Suppli‐Ulrik Ioanna Tsiligianni Antonio Valero Arūnas Valiulis Erkka Valovirta Tuula Vasankari Maria Teresa Ventura Dana Wallace De Yun Wang Siân Williams Arzu Yorgancıoğlu Osman Yusuf Mario Zernotti Jean Bousquet Ludger Klimek

Although there are many asymptomatic patients, one of the problems COVID-19 is early recognition disease. symptoms polymorphic and may include upper respiratory symptoms. However, be mistaken with common cold or allergic rhinitis. An ARIA-EAACI study group attempted to differentiate between three diseases.A modified Delphi process was used. The ARIA members who were seeing patients asked fill in a questionnaire on airway COVID-19, rhinitis.Among 192 invited respond questionnaire, 89...

10.1111/all.14815 article EN Allergy 2021-03-17

Validated combined symptom-medication scores (CSMSs) are needed to investigate the effects of allergic rhinitis treatments. This study aimed use real-life data from MASK-air® app generate and validate hypothesis- data-driven CSMSs.We used assess concurrent validity, test-retest reliability responsiveness one hypothesis-driven CSMS (modified CSMS: mCSMS), mixed score (mixed score), several CSMSs. The latter were generated with following cluster analysis regression models or factor analysis....

10.1111/all.15199 article EN cc-by-nc-nd Allergy 2021-12-21

Co-medication is common among patients with allergic rhinitis (AR), but its dimension and patterns are unknown. This particularly relevant since AR understood differently across European countries, as reflected by rhinitis-related search in Google Trends. study aims to assess co-medication regional Europe, using real-world data. We analysed 2015-2020 MASK-air® compared days under no medication, monotherapy the visual analogue scale (VAS) levels for overall symptoms ('VAS Global Symptoms')...

10.1111/all.15275 article EN cc-by-nc-nd Allergy 2022-03-08
Jean Bousquet Josep M Antó Bernardo Sousa‐Pinto Heather J. Zar Anna Bedbrook and 95 more Tari Haahtela Ludger Klimek Oliver Pfaar Piotr Kuna Maciej Kupczyk Frederico S. Regateiro Bolesław Samoliński Arūnas Valiulis Arzu Yorgancıoğlu S. Arnavielhe Xavier Basagaña Karl‐Christian Bergmann Sinthia Bosnic‐Anticevich Luisa Brussino Giorgio Walter Canonica Victòria Cardona Lorenzo Cecchi Cláudia Chaves Loureiro Elı́sio Costa Ãlvaro A. Cruz Bilun Gemicioğlu Wytske J. Fokkens Juan Carlos Ivancevich Helga Kraxner Violeta Kvedarienė Désirée Larenas‐Linnemann Daniel Laune Renaud Louis Michaël Makris Marcus Maurer Erik Melén Yann Micheli Mário Morais‐Almeida Joaquim Mullol Marek Niedoszytko Yoshitaka Okamoto Nikolaos G. Papadopoulos Vincenzo Patella N. Pham‐Thi Philip W. Rouadi J. Sastre Nicola Scichilone Aziz Sheikh Mikhail Sofiev Luís Taborda‐Barata Sanna Toppila‐Salmi Ioanna Tsiligianni Erkka Valovirta Maria Teresa Ventura Rafael José Vieira Mihaela Zidarn Rita Amaral Ignacio J. Ansotegui Annabelle Bédard Samuel Benveniste M. Bewick Carsten Bindslev‐Jensen Hubert Blain Matteo Bonini Rodolphe Bourret Fulvio Braido Pedro Martins D. Charpin Iván Chérrez-Ojeda Tomás Chivato Derek K. Chu Cemal Cingi Stefano Del Giacco F. de Blay Philippe Devillier Govert De Vries Maria Doulaptsi V. Doyen Gérard Dray J.F. Fontaine René Maximiliano Gómez Jan Hagemann Enrico Heffler Maja A. Hofmann Ewa Jassem Marek Jutel Thomas Keil Vicky Kritikos Inger Kull Marek Kulus Olga Lourenço Eve Mathieu‐Dupas Enrica Menditto Ralph Mösges Ruth Murray Rachel Nadif Hugo Neffen Stefania Nicola Robyn E. O’Hehir Heidi Olze

MASK-air

10.1002/clt2.12215 article EN cc-by Clinical and Translational Allergy 2023-01-01

Validated questionnaires are used to assess asthma control over the past 1-4 weeks from reporting. However, they do not adequately capture in patients with fluctuating symptoms. Using Mobile Airways Sentinel Network for airway diseases (MASK-air) app, we developed and validated an electronic daily score (e-DASTHMA).We MASK-air data (freely available users 27 countries) develop different scores asthma. Data-driven were based on symptoms reported by a visual analogue scale (VAS) self-reported...

10.1016/s2589-7500(23)00020-1 article EN cc-by The Lancet Digital Health 2023-03-03

Adherence to rhinitis treatment has been insufficiently assessed. We aimed use data from the MASK-air mHealth app assess adherence oral antihistamines (OAH), intra-nasal corticosteroids (INCS) or azelastine-fluticasone in patients with allergic rhinitis. included regular European users self-reported and reporting at least 1 day of OAH, INCS azelastine-fluticasone. assessed weeks during which answered questionnaire on all days. restricted our analyses provided between January June, encompass...

10.1111/cea.70004 article EN cc-by Clinical & Experimental Allergy 2025-02-16

Immunoglobulin E (IgE)-mediated hypersensitivity reactions to neuromuscular blocking agents (NMBA) are common and life threatening. Basophil activation based upon the expression of CD63 in presence specific allergens was found be importance for diagnosis IgE-mediated hypersensibility.The Basotest evaluated NMBA 47 patients with proven anaphylaxis, 40 atopic subjects nonallergic five healthy volunteers. Diagnosis made according international standards on clinical history, skin tests...

10.1111/j.1398-9995.2006.00978.x article EN Allergy 2006-01-23

Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data assess the impact on work productivity uncontrolled assessed by visual analogue scale (VAS). A mobile app (Allergy Diary, Google Play Store Apple App Store) collects from daily scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) asthma (VAS-asthma) as well (VAS-work). combined nasal-ocular score is calculated....

10.1111/all.13177 article EN Allergy 2017-04-07
Coming Soon ...